Table 1: Demographic, clinical and laboratory values of all patients included in
the study.
|
DM (-) PAH (n:55) |
DM (+) PAH(n:24) |
p |
|
|
Age mean±standard
deviation |
58±9,70 |
54 ±10,01 |
0.2* |
|
Gender |
Male: 28 (%50.9) Female: 27 (%49.1) |
Male:10 (% 41.7) Female:14 (%58.3) |
0.45** |
|
Chronic disease |
20 (%29) |
49 (%71) |
0.479** |
|
Smoking |
6 (17,6%) |
28 (82,4%) |
0.004 |
|
Haptoglobilin
(g/L) mean±standard
deviation |
1877,01±564,67 |
1745,94±612,59 |
0.358* |
|
25-hidroxylase (CYP2R1) (ng/ml) |
51,41 (2,53- 2722,18) |
25,36 (9,43- 624,57 |
0.332*** |
|
Endocan (ESM1) (pg/ml) |
157,9506(29,16- 7026,64) |
586,23 65(138,79- 3876,51) |
p<0.001*** |
n: number of individuals, * Student t testi, **
Ki-kare testi, ***Mann-Whitney
U test.